BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Thunold RF, Løkke A, Cohen AL, Ole H, Bendstrup E. Patient reported outcome measures (PROMs) in sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis 2017;34:2-17. [PMID: 32476819 DOI: 10.36141/svdld.v34i1.5760] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
Number Citing Articles
1 Atkins C, Jones A, Clark AB, Stockl A, Fordham R, Wilson AM. Feasibility of investigating methylphenidate for the treatment of sarcoidosis-associated fatigue (the FaST-MP study): a double-blind, parallel-arm randomised feasibility trial. BMJ Open Respir Res 2021;8:e000814. [PMID: 34020962 DOI: 10.1136/bmjresp-2020-000814] [Reference Citation Analysis]
2 Gvozdenovic BS, Mihailovic-Vucinic VV, Vukovic MH, Stjepanovic MI, Buha I, Mihailovic SV, Maric NB. Predictors of cough-specific and generic quality of life in sarcoidosis patients. Sarcoidosis Vasc Diffuse Lung Dis 2020;37:158-68. [PMID: 33093779 DOI: 10.36141/svdld.v37i2.9234] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
3 Harman NL, Gorst SL, Williamson PR, Barnathan ES, Baughman RP, Judson MA, Junk H, Kampstra NA, Sullivan EJ, Victorson DE, Walton M, Al-Hakim T, Nabulsi H, Singh N, Grutters JC, Culver DA. Scout - sarcoidosis outcomes taskforce. A systematic review of outcomes to inform the development of a core outcome set for pulmonary sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis 2021;38:e2021034. [PMID: 34744426 DOI: 10.36141/svdld.v38i3.10737] [Reference Citation Analysis]